Copyright © Inderes 2011 - present. All rights reserved.
Log in to receive notifications.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Regulatory press release

GENT: Disclosure of shareholding

Gentian Diagnostics
Viola AS, a wholly-owned subsidiary of Rasmussengruppen AS, acquired 150,000
shares in Gentian Diagnostics ASA (the "Company") on 14 December 2023 with
settlement on 18 December 2023.

As a result of the transaction, companies wholly-owned by Rasmussengruppen AS
increased their consolidated holding of shares in the Company from 705,916 to
855,916 shares, equal to an increase from approximately 4.58% to approximately
5.55% of the votes and shares in the Company. The shares are held by Viola AS
(320,916 shares), Portia AS (300,000 shares) and Cressida AS (235,000).

The above mentioned companies have no other rights to shares issued by the
Company.

This announcement is made in accordance with Section 4-2 of the Norwegian
Securities Trading Act.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team